193 related articles for article (PubMed ID: 37045940)
1. DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors.
Laranjeira ABA; Hollingshead MG; Nguyen D; Kinders RJ; Doroshow JH; Yang SX
Sci Rep; 2023 Apr; 13(1):5964. PubMed ID: 37045940
[TBL] [Abstract][Full Text] [Related]
2. Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.
Thottassery JV; Sambandam V; Allan PW; Maddry JA; Maxuitenko YY; Tiwari K; Hollingshead M; Parker WB
Cancer Chemother Pharmacol; 2014 Aug; 74(2):291-302. PubMed ID: 24908436
[TBL] [Abstract][Full Text] [Related]
3. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
5. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.
Ghoshal K; Datta J; Majumder S; Bai S; Kutay H; Motiwala T; Jacob ST
Mol Cell Biol; 2005 Jun; 25(11):4727-41. PubMed ID: 15899874
[TBL] [Abstract][Full Text] [Related]
6. 5-Aza-4'-thio-2'-deoxycytidine, a New Orally Bioavailable Nontoxic "Best-in-Class": DNA Methyltransferase 1-Depleting Agent in Clinical Development.
Parker WB; Thottassery JV
J Pharmacol Exp Ther; 2021 Nov; 379(3):211-222. PubMed ID: 34503994
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.
Alcazar O; Achberger S; Aldrich W; Hu Z; Negrotto S; Saunthararajah Y; Triozzi P
Int J Cancer; 2012 Jul; 131(1):18-29. PubMed ID: 21796622
[TBL] [Abstract][Full Text] [Related]
8. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells.
Yang J; Tian X; Yang J; Cui J; Jiang S; Shi R; Liu Y; Liu X; Xu W; Xie W; Jia X; Bade R; Zhang T; Zhang M; Gong K; Yan S; Yang Z; Shao G
J Toxicol Environ Health A; 2017; 80(22):1222-1229. PubMed ID: 28880816
[TBL] [Abstract][Full Text] [Related]
9. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1.
Maslov AY; Lee M; Gundry M; Gravina S; Strogonova N; Tazearslan C; Bendebury A; Suh Y; Vijg J
Oncogene; 2012 Dec; 31(50):5172-9. PubMed ID: 22349820
[TBL] [Abstract][Full Text] [Related]
10. 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9.
Lin C; Xie Y; Huang W; Lin D; Lin L
Exp Hematol; 2022 Oct; 114():43-53.e2. PubMed ID: 35908628
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE
Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325
[TBL] [Abstract][Full Text] [Related]
12. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms.
Schneider-Stock R; Diab-Assef M; Rohrbeck A; Foltzer-Jourdainne C; Boltze C; Hartig R; Schönfeld P; Roessner A; Gali-Muhtasib H
J Pharmacol Exp Ther; 2005 Feb; 312(2):525-36. PubMed ID: 15547111
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.
Palii SS; Van Emburgh BO; Sankpal UT; Brown KD; Robertson KD
Mol Cell Biol; 2008 Jan; 28(2):752-71. PubMed ID: 17991895
[TBL] [Abstract][Full Text] [Related]
14. Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme.
Patel K; Dickson J; Din S; Macleod K; Jodrell D; Ramsahoye B
Nucleic Acids Res; 2010 Jul; 38(13):4313-24. PubMed ID: 20348135
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.
Hassler MR; Klisaroska A; Kollmann K; Steiner I; Bilban M; Schiefer AI; Sexl V; Egger G
Biochimie; 2012 Nov; 94(11):2297-307. PubMed ID: 22687603
[TBL] [Abstract][Full Text] [Related]
16. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines.
Hagemann S; Heil O; Lyko F; Brueckner B
PLoS One; 2011 Mar; 6(3):e17388. PubMed ID: 21408221
[TBL] [Abstract][Full Text] [Related]
17. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.
Jung Y; Park J; Kim TY; Park JH; Jong HS; Im SA; Robertson KD; Bang YJ; Kim TY
J Mol Med (Berl); 2007 Oct; 85(10):1137-48. PubMed ID: 17571247
[TBL] [Abstract][Full Text] [Related]
18. The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells.
Yan F; Shen N; Pang J; Molina JR; Yang P; Liu S
J Biol Chem; 2015 Jul; 290(30):18480-94. PubMed ID: 26085088
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors.
Li A; Omura N; Hong SM; Goggins M
Cancer Biol Ther; 2010 Feb; 9(4):321-9. PubMed ID: 20234167
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor.
Gray SG; Baird AM; O'Kelly F; Nikolaidis G; Almgren M; Meunier A; Dockry E; Hollywood D; Ekström TJ; Perry AS; O'Byrne KJ
Int J Mol Med; 2012 Dec; 30(6):1505-11. PubMed ID: 23007409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
